Ciloa SAS logo

Ciloa SAS

Inspired by Exosomes

12 employees · est. 2011 · Montpellier, France

VS
iBio, Inc. logo

iBio, Inc.

AI-Powered Precision Antibody Therapeutics

50 employees · est. 2008 · San Diego, United States

iBio, Inc. is the older company (2011 vs 2008).

Side-by-Side Comparison

Ciloa SAS iBio, Inc.
Founded
2011 2008 older
Headquarters
Montpellier, France San Diego, United States
Employees
12 50
Industry
Health and Wellness, Legal Tech Biotechnology, Robotics
Funding Stage
Series Unknown Post Ipo Equity
Total Funding
$5.00M $53.14M
Funding Rounds
1 6
Services
Development of therapies using exosome bioengineering, Production of native membrane proteins on exosomes, Therapeutic and preventive vaccines Not tracked yet
Target Customers
Biotechnology researchers, Pharmaceutical companies, Healthcare providers, Academic technology platforms Not tracked yet
Taxonomy
Exosome-based Therapeutics, Membrane Protein Complexes, Customizable Exosomes, Therapeutic Vectors, Antibody Development, Vaccine Development, Virus-Free Solutions, Undruggable Targets, Bio-drug R&D, Membrane Protein Conformation, Cytosolic Protein Loading, Blood-Brain Barrier Traversal, Intercellular Communication, Biocompatible Therapies, Licensing And Partnerships AI-powered Drug Discovery, Precision Medicine, Immunotherapy, Antibody Therapeutics, Biopharmaceuticals, Cancer Treatment, Artificial Intelligence In Drug Development, Monoclonal Antibodies, Biologics Production, Green Plant Transient Gene Expression, Bioprocessing Technology, Drug Target Identification, Immuno-oncology, Biosimilar Products, Pandemic Disease Response
Website
ciloa.fr ibioinc.com
Ciloa SAS logo

About Ciloa SAS

Ciloa SAS, founded in 2011 and headquartered in France, positions itself at the forefront of the biotech industry with its slogan, "Inspired by Exosomes." Specializing in exosome-based research and development, the company focuses on creating innovative therapeutics that address traditionally undrug...

iBio, Inc. logo

About iBio, Inc.

iBio, Inc. is a biotechnology startup founded in 2008, based in the United States, with a mission to develop safer and more effective immunotherapies for challenging cancers through their Discovery Platform. The company's slogan "AI-Powered Precision Antibody Therapeutics" highlights their use of ar...

We will tell you when either one moves

BounceWatch watches Ciloa SAS and iBio, Inc. for new funding, fast hiring, new executives and a change of software vendor. When one happens, we email you the same day.

Watch both — free

Funding, hiring, leadership and stack changes at Ciloa SAS and iBio, Inc. — by email.

Frequently Asked Questions

Ciloa SAS — Inspired by Exosomes. iBio, Inc. — AI-Powered Precision Antibody Therapeutics. Both companies operate in related markets but may differ in funding stage, team size, and product focus.
Ciloa SAS has raised $5.00M while iBio, Inc. has raised $53.14M.
Ciloa SAS and iBio, Inc. operate in overlapping markets and are frequently compared. Track both companies on Bounce Watch to monitor their growth signals in real time.

Compare Ciloa SAS with someone else

Start typing a company name or domain.

Compiled from the BounceWatch company index. We last looked at Ciloa SAS on 3 Mar 2026, and iBio, Inc. on 14 Sep 2024. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.

One analytics cookie (Google Analytics). Cookie Policy